Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin–lysoPA axis in COPD
暂无分享,去创建一个
Å. Wheelock | C. Wheelock | Mingxing Yang | S. Snowden | Bettina Levänen | D. Erle | C. Sköld | J. Kolmert | M. A. Kamleh | S. Naz | S. Reinke | Tina Heyder
[1] Stacey N. Reinke,et al. Metabolomics analysis identifies different metabotypes of asthma severity , 2017, European Respiratory Journal.
[2] B. Topçu,et al. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD , 2015, The clinical respiratory journal.
[3] J. Vandesompele,et al. MicroRNA Profiling Reveals a Role for MicroRNA‐218‐5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease , 2017, American journal of respiratory and critical care medicine.
[4] T. To,et al. Progression from Asthma to Chronic Obstructive Pulmonary Disease. Is Air Pollution a Risk Factor? , 2016, American journal of respiratory and critical care medicine.
[5] S. Rouatbi,et al. Incapacity, Handicap, and Oxidative Stress Markers of Male Smokers With and Without COPD , 2016, Respiratory Care.
[6] Miranda Kirby,et al. Sex Differences in Airway Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease. , 2016, American journal of respiratory and critical care medicine.
[7] Willem-Jan Keune,et al. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling , 2016, Nature Communications.
[8] S. Dahlén,et al. Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD , 2016, European Respiratory Journal.
[9] I. Horváth,et al. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker , 2016, COPD.
[10] K. Pinkerton,et al. Pulmonary health effects of air pollution , 2016, Current opinion in pulmonary medicine.
[11] Fabian J Theis,et al. Metabolomics screening identifies reduced L-carnitine to be associated with progressive emphysema. , 2016, Clinical science.
[12] J. Christman,et al. Polyunsaturated lysophosphatidic acid as a potential asthma biomarker. , 2016, Biomarkers in medicine.
[13] Peijian He,et al. Autotaxin-LPA receptor axis in the pathogenesis of lung diseases. , 2015, International journal of clinical and experimental medicine.
[14] S. Dupont,et al. Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in COPD , 2015 .
[15] B. Rowe,et al. Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases. , 2015, The Journal of allergy and clinical immunology.
[16] A. Usheva,et al. Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury , 2015, Purinergic Signalling.
[17] D. Postma,et al. Unravelling the complexity of COPD by microRNAs: it's a small world after all , 2015, European Respiratory Journal.
[18] J. Lü,et al. The role of miR-29 in pulmonary fibrosis. , 2015, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[19] C. Dodia,et al. Inhibition of the phospholipase A2 activity of peroxiredoxin 6 prevents lung damage with exposure to hyperoxia , 2015, Redox biology.
[20] David G. Watson,et al. LC–MS Metabolomics of Psoriasis Patients Reveals Disease Severity-Dependent Increases in Circulating Amino Acids That Are Ameliorated by Anti-TNFα Treatment , 2014, Journal of proteome research.
[21] B. Maskrey,et al. 12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition , 2014, Journal of Inflammation.
[22] N. Ferreirós,et al. Serum Autotaxin Is a Parameter for the Severity of Liver Cirrhosis and Overall Survival in Patients with Liver Cirrhosis – A Prospective Cohort Study , 2014, PloS one.
[23] Y. Cheng,et al. c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT , 2014, Oncogene.
[24] Piotr S. Gromski,et al. Influence of Missing Values Substitutes on Multivariate Analysis of Metabolomics Data , 2014, Metabolites.
[25] L. Paz-Ares,et al. MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD , 2014, European Respiratory Journal.
[26] Å. Wheelock,et al. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction. , 2014, Chest.
[27] Junhua Wu,et al. Diverse roles of miR-29 in cancer (review). , 2014, Oncology reports.
[28] G. Gauvreau,et al. Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD) , 2014, International journal of molecular sciences.
[29] Å. Wheelock,et al. Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers , 2014, Respiratory Research.
[30] S. Georas,et al. The Autotaxin–LPA Axis Emerges as a Novel Regulator of Lymphocyte Homing and Inflammation , 2014, The Journal of Immunology.
[31] G. Prestwich,et al. Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. , 2013, American journal of respiratory and critical care medicine.
[32] Åsa M Wheelock,et al. Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine. , 2013, Molecular bioSystems.
[33] S. Kjellqvist,et al. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. , 2013, The Journal of allergy and clinical immunology.
[34] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[35] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[36] M. Love,et al. Airway epithelial miRNA expression is altered in asthma. , 2012, American journal of respiratory and critical care medicine.
[37] David Broadhurst,et al. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. , 2012, Bioanalysis.
[38] J. Riley,et al. Metabolic profiling detects biomarkers of protein degradation in COPD patients , 2011, European Respiratory Journal.
[39] P. Pencharz,et al. Asymmetric dimethylarginine is increased in asthma. , 2011, American journal of respiratory and critical care medicine.
[40] Timothy M. D. Ebbels,et al. Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA , 2011 .
[41] S. Gabrielsson,et al. Differences In Exosomal Micrornas In Bronchoalveolar Lavage Fluid From Asthmatics And Healthy Individuals , 2011, ATS 2011.
[42] Edwin K Silverman,et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[43] F. Di Virgilio,et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[44] D. DeMeo,et al. Gender differences in COPD: are women more susceptible to smoking effects than men? , 2010, Thorax.
[45] E. Silverman,et al. Sex differences in emphysema and airway disease in smokers. , 2009, Chest.
[46] Wlodzimierz ‘Vlady’ Rozenbaum,et al. Patients with Chronic Obstructive Pulmonary Disease , 2008 .
[47] D. Hermanson. What I Have Learned So Far: Observations on Managing an Academic Accounting Career , 2008 .
[48] H. Boezen,et al. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies , 2008, European Respiratory Journal.
[49] U. Edlund,et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. , 2008, Analytical chemistry.
[50] Meilan K. Han,et al. Gender and chronic obstructive pulmonary disease: why it matters. , 2007, American journal of respiratory and critical care medicine.
[51] D. Mannino,et al. Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.
[52] W. Moolenaar,et al. Regulation and biological activities of the autotaxin-LPA axis. , 2007, Progress in lipid research.
[53] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[54] A. Smilde,et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. , 2006, Analytical chemistry.
[55] C. Vogelmeier,et al. [Pathogenesis of chronic obstructive pulmonary disease]. , 2006, Der Internist.
[56] I. Adcock,et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.
[57] P. Roe,et al. Pulmonary disease , 1991 .
[58] T. Murohara,et al. Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation. , 1998, Circulation.
[59] W. J. Krzanowski,et al. A User's Guide to Principal Components , 1992 .